ArticleWellcome open research2026
Defining prevalence of atopic dermatitis in the Avon Longitudinal Study of Parents and Children (ALSPAC).
Article in Wellcome open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Longitudinal cohorts with repeated assessments of atopic dermatitis prevalence and severity are rare. Herein, we describe repeated measures from questionnaires and clinical assessments pertaining to dermatitis in the Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort with the goal of promoting clear and consistent definitions in research. In total, there were 22 time points wherein data were collected relevant to atopic dermatitis (AD). The period prevalence of maternal- or self-reported "rash" in the past 12 months ranged from 11% to 46% across 14 timepoints, with a cumulative prevalence of 80% by age 18. The period prevalence of participant-reported "eczema" in the past 12 months ranged from 13% to 16% across 7 timepoints, with a cumulative prevalence of 29% by age 16. The annual maternal or self-reported period prevalence of "flexural dermatitis," based on a question similar to large epidemiologic studies, ranged from 14% to 27% across 13 timepoints, with a cumulative prevalence of 57% by age 18. Self-reported point prevalence of flexural dermatitis matched well with estimates from clinical examinations at 6 time points. Additional data on associated infections, medication use, sleep, and school absences are available at limited time points. Based on the quality and consistency of data, we propose creating a new definition of "active" AD: at least 2 reports of flexural dermatitis, up to and including the time point being considered. The annual maternal or self-reported period prevalence of atopic dermatitis based on the 2-report definition ranged from 13-21% across 12 timepoints, with a cumulative prevalence of 41% by age 18, similar to population-based estimates for the UK.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.